FOLLICULAR LYMPHOMA (FL)
Clinical trials for FOLLICULAR LYMPHOMA (FL) explained in plain language.
Never miss a new study
Get alerted when new FOLLICULAR LYMPHOMA (FL) trials appear
Sign up with your email to follow new studies for FOLLICULAR LYMPHOMA (FL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
CAR-T therapy takes on tough lymphoma in Head-to-Head trial
Disease control OngoingThis phase 3 trial tests whether a personalized cell therapy called tisagenlecleucel (CAR-T) works better than standard treatments for adults with follicular lymphoma that has come back or stopped responding. About 109 participants will receive either the CAR-T infusion or standa…
Matched conditions: FOLLICULAR LYMPHOMA (FL)
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New drug combo shows promise in lymphoma battle
Disease control OngoingThis study tests a new drug, odronextamab, combined with chemotherapy for people with untreated follicular lymphoma, a type of blood cancer. It compares this new combo to the standard treatment (rituximab plus chemo) to see which works better. About 733 adults will take part, and…
Matched conditions: FOLLICULAR LYMPHOMA (FL)
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
15-Year watch begins for new cancer cell therapy
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 18 people who previously received GF-CART01, a CAR T-cell therapy for certain blood cancers like lymphoma. Researchers will track side effects and how long the modified cells last in the body for up to 15 years. The goal is to ensure the treatment remains safe …
Matched conditions: FOLLICULAR LYMPHOMA (FL)
Sponsor: GenomeFrontier Therapeutics TW Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC